Peter Blenkinsop joined a panel — along with Efstathia Gkika, associate GC at Baxter Healthcare’s Privacy, Cybersecurity & Digital EU Data Privacy Office; and Veronique Brokke, lead privacy counsel at Philips — presenting on “Conducting R&D While Navigating Through an Increasingly Complex Privacy Landscape in Europe and Beyond” at MedTech Forum 2022.
Digital technology is opening opportunities for all players in the health care sector, but it also creates specific challenges for medical technology companies in particular. In the past, medtech companies typically relied on a highly regulated and lengthy research and development (R&D) phase focused on the launch of an end-product. Today, in view of digital/connected products, in addition to this regulatory framework, there is another challenge, which is the need to navigate the privacy regulations around the world when conducting R&D for software-based solutions.
This session aimed at discussing this particular privacy thorn in the R&D phase of digital products and brainstormed on potential solutions, ranging from regulatory harmonization to the development of sector-specific standards or codes of conduct.
The MedTech Forum, the leading MedTech conference in Europe